Literature DB >> 6430443

Metformin and glibenclamide: comparative risks.

I W Campbell.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6430443      PMCID: PMC1442167          DOI: 10.1136/bmj.289.6440.289

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  3 in total

1.  Lactic acidosis during metformin treatment in an elderly diabetic patient with impaired renal function.

Authors:  L S Hermann; S Magnusson; B Möller; C Casey; G T Tucker; H F Woods
Journal:  Acta Med Scand       Date:  1981

2.  Glibenclamide-associated hypoglycaemia: a report on 57 cases.

Authors:  K Asplund; B E Wiholm; F Lithner
Journal:  Diabetologia       Date:  1983-06       Impact factor: 10.122

3.  The status of metformin in Canada.

Authors:  O J Lucis
Journal:  Can Med Assoc J       Date:  1983-01-01       Impact factor: 8.262

  3 in total
  9 in total

Review 1.  [Value of biguanide in therapy of diabetes mellitus].

Authors:  E Haupt; U Panten
Journal:  Med Klin (Munich)       Date:  1997-08-15

2.  Treatment of type II diabetes.

Authors:  J S Yudkin
Journal:  Br Med J (Clin Res Ed)       Date:  1986-05-10

3.  Effects of Metformin and a Mammalian Target of Rapamycin (mTOR) ATP-Competitive Inhibitor on Targeted Metabolomics in Pancreatic Cancer Cell Line.

Authors:  Ghada A Soliman; Sharalyn M Steenson; Asserewou H Etekpo
Journal:  Metabolomics (Los Angel)       Date:  2016-08-20

4.  Sulphonylureas and hypoglycaemia.

Authors:  R E Ferner; H A Neil
Journal:  Br Med J (Clin Res Ed)       Date:  1988-04-02

5.  Metformin-associated lactic acidosis in Sweden 1977-1991.

Authors:  B E Wiholm; M Myrhed
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 6.  Comparative tolerability profiles of oral antidiabetic agents.

Authors:  A J Krentz; R E Ferner; C J Bailey
Journal:  Drug Saf       Date:  1994-10       Impact factor: 5.606

Review 7.  Drug administration in patients with diabetes mellitus. Safety considerations.

Authors:  R E Gilbert; M E Cooper; H Krum
Journal:  Drug Saf       Date:  1998-06       Impact factor: 5.606

Review 8.  Features, prevention and management of acute overdose due to antidiabetic drugs.

Authors:  D F Moore; D F Wood; G N Volans
Journal:  Drug Saf       Date:  1993-09       Impact factor: 5.606

9.  Changes in metformin use in chronic kidney disease.

Authors:  Talha H Imam
Journal:  Clin Kidney J       Date:  2017-03-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.